denosumab
daiichi sankyo,amgen
['denosumab']
late breaking at #acr22 denosumab treatment improved radiographic damage in erosive hand osteoarthritis; improvements in clinical outcomes like pain required much longer treatment 
The #LancetRheumatology is a clinical #rheumatology journal publishing innovative & practice-changing research & opinion across all #rheumatic & #MSK disorders